Evidence map›Paper›PMID 36742111›Full record

ArticleFrontiers in tropical diseases2022

Bio-products from

Esinam Abla Akorli, Prince Chigozirim Ubiaru, Sabyasachi Pradhan, Jewelna Akorli, Lisa Ranford-Cartwright

Open access · goldAbstract read
In one paragraph

Article in Frontiers in tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Esinam Abla AkorliDepartment of Parasitology, Noguchi Memorial Institute of Medical Research, University of Ghana, Legon Accra, Ghana.
Prince Chigozirim UbiaruSchool of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Graham Kerr Building, Glasgow, United Kingdom.
Sabyasachi PradhanSchool of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Graham Kerr Building, Glasgow, United Kingdom.
Jewelna AkorliDepartment of Parasitology, Noguchi Memorial Institute of Medical Research, University of Ghana, Legon Accra, Ghana.
Lisa Ranford-CartwrightSchool of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Graham Kerr Building, Glasgow, United Kingdom.
University of Glasgow · GBNoguchi Memorial Institute for Medical Research · GHUniversity of Ghana · GH

Funding

Wellcome Trust 220737
6 · The paper itself

Abstract

Novel ideas for control of mosquito-borne disease include the use of bacterial symbionts to reduce transmission. Bacteria belonging to the family Enterobacteriaceae isolated from mosquito midgut have shown promise in limiting

Indexed as

Anopheles gambiae s.lbacterial bio-productsdisease transmission blockingEnterobacter cloacaemosquito midgut microbiotaPlasmodium falciparumSerratia marcescens

Identifiers

PMID36742111
PMCPMC7614139
OpenAlexW4298140788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.